We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Study of hepatoprotective effects of xymedon.
- Authors
Vyshtakalyuk, A B; Nazarov, N G; Zueva, I V; Lantsova, A V; Minnekhanova, O A; Busygin, D V; Porfiryev, A G; Evtyugin, V G; Reznik, V S; Zobov, V V
- Abstract
Xymedon (1-(β-oxyethyl)-4,6-dimethyl-1,2-dihydro-2-oxopyrimidine), a regeneratory and wound-healing drug, exhibited hepatoprotective activity in laboratory animals with experimental toxic hepatitis. Oral drug reduced the severity of toxic involvement of the liver induced by CCl4 and reduced animal mortality. Xymedon promoted recovery of the blood biochemical parameters characterizing the liver status.
- Publication
Bulletin of experimental biology and medicine, 2013, Vol 155, Issue 5, p643
- ISSN
1573-8221
- Publication type
Journal Article
- DOI
10.1007/s10517-013-2215-0